Close Banner
Section Free  - Video Lectures

06. Antidepressants During Breastfeeding

Published on August 1, 2021 Expired on April 1, 2025

Lauren Osborne, M.D.

Vice Chair of Clinical Research in the Department of Obstetrics and Gynecology - Weill Cornell Medicine

Key Points

  • SSRIs have low passage into the breastmilk and are considered compatible with breastfeeding.
  • There is no reason to stop fluoxetine for breastfeeding if it works well for the patient.
  • Older drugs have more data.
  • Sertraline has the lowest passage into breastmilk.
  • Choose the drug that works for the patient.
  • Other classes of antidepressants are also considered compatible with breastfeeding.

Free Downloads for Offline Access

  • Free Download Video (MP4)
  • Free Download Audio File (MP3)
  • Free Download Presentation File (PPTX)

Slides and Transcript

Slide 1 of 22

We're now turning to the section of the talk that's going to be about specific medications and their use during breastfeeding. I'm going to divide this up into sections on different classes of medications and I'll work in some clinical vignettes for most of these types of drugs so that you can see how to apply these principles to your patients.

Slide 2 of 22

Remember that older drugs have more evidence. So, if you're starting from scratch and you want to use a drug for the first time, choose something that's older because it will have more evidence. For the SSRIs, for example, this means that the older SSRIs are drugs for which we've collected a lot of evidence. Those new drugs that have come out in the last few years, we don't know anything about their use in breastfeeding. Chances are they're fine, but we don't actually have any data.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 3 of 22

We have no evidence also that timing of the drug dose relative to timing of feedings makes any difference. So, I think a lot of doctors will give advice that "well, you should feed the baby and then take your sertraline." But we don't actually have any evidence that that makes a difference so I wouldn't advise women that way.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.

Slide 4 of 22

Fortunately, the SSRI medications all have low passage into the breastmilk, and they're all considered compatible with breastfeeding.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 5 of 22

One thing to be aware of is poor neonatal adaptation syndrome which may occur in up to 30% of babies who are exposed to SSRIs in utero. This is a behavioral syndrome that usually goes away by about two weeks postpartum, and it's characterized by fussiness, difficulty feeding and other behavioral symptoms in the postpartum.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.

Slide 6 of 22

We don't really know what it is whether it's withdrawal, toxicity or something else because it's also observed in babies whose mothers did not take SSRIs in utero. But there's some evidence that it may be lessened in breastfed babies. So that's actually one advantage to a woman who used the medication in pregnancy staying on that medication in breastfeeding.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 7 of 22

Sertraline is the drug that's probably best studied in breastfeeding and has the lowest passage into breastmilk. So, it's often a go-to for women who are starting a drug for the first time in the postpartum.
References:
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.

Slide 8 of 22

Fluoxetine has a very long half-life which at first led to theoretical concerns about increased adverse effects for infants. And in fact, there are more case reports of sedation and colic for fluoxetine than for other SSRI medications. That may mean that it wouldn't be your first choice for a mother who is SSRI naïve and needs to go on medication for the first tine in the postpartum.
References:
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 9 of 22

It doesn't mean, however, that it should be stopped in mothers who are already using it. We know that certain people respond to certain antidepressants, and we can't figure out why. So, if you have a mother who's has had a good response with fluoxetine in the past, I wouldn't use that theoretical concern about increased effects in the infant as a reason not to use fluoxetine. I'd try it and observe.
References:
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.

Slide 10 of 22

What about things other than SSRIs? Well, we use them less often in the perinatal period simply because side effects of other classes of antidepressants tend to be higher, but we don't actually have any known contraindications for these medications in breastfeeding.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 11 of 22

The tricyclic antidepressants have all been studied and there's no evidence of excess adverse effects with this class. There are, however, more cases of hypotonia, poor suckling and vomiting with doxepin as opposed to some of the other TCAs.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader

Slide 12 of 22

For bupropion which is used frequently in women of childbearing age, there's a theoretical concern that it could lower the seizure threshold when used in high doses. And in fact, we have one published case report of an infant who had a seizure but it's only one published case report. What that leads you to do in the clinical situation is use this drug with caution in a baby who has other reasons for being at risk for seizure but it's not a reason not to use the drug in babies who don't have an excess seizure risk.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 13 of 22

We have limited information on mirtazapine. So, it's a newer drug that we don't have as much as information on but the information we have gives no evidence of adverse effects. And as I mentioned before, among the SSRIs, those newer drugs, we just simply don't have any evidence so I would stick to the older drugs when possible.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
  • Drugs and lactation database: (LactMed). (2006). National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/?report=reader

Slide 14 of 22

Let's talk about how to apply this to a particular patient. Our patient today is Mary Jones. She's 34 years old and she is three weeks postpartum with her first child.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 15 of 22

She was referred by her obstetrician for two weeks of difficulty sleeping, worries about the baby and her health, poor appetite and concentration. She feels her baby might be better off without her.

Slide 16 of 22

Prior history, let's imagine two different scenarios because they're going to affect what drug we choose. First scenario, this patient has had one prior episode of depression that resolved without treatment. She's never used psychiatric medication. She's got no family history of medication response to a particular medication. Scenario number 2, we're going to give her a prior history of multiple episodes with severe symptoms. She is not responding to sertraline or citalopram in the past, but she was stable for several years on fluoxetine.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 17 of 22

So, let's say for either of these two scenarios, Mary's baby was born full term, healthy weight with no complications and no medical comorbidities. There's no reason to calculate the relative infant dose here. We're looking at commonly used drugs with a lot of published literature about the milk-to-plasma ratio and nothing about the baby that makes me think this is an unusual situation. Symptoms are straightforward.

Slide 18 of 22

In scenario number 1 where she had one prior episode and never used medications, we'll choose to start the patient on sertraline. It has the best evidence of the lowest passage into the breastmilk, and we'll titrate it up to the therapeutic dose. In scenario number 2, however, where the patient had previously not responded to sertraline or citalopram but had several years of stability on fluoxetine, we would instead start the patient on fluoxetine. Remember there's a theoretical risk of increased adverse reactions due to long half-life but a good history that this works well for the patient.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 19 of 22

So, we'd try fluoxetine. We'd advise her to monitor the patient for drowsiness. We'd contact the pediatrician to explain our reasoning and we'd watch carefully. We can always switch to something else if there's an adverse reaction, but we know this medication will work best for the mother.
References:
  • Begg, E. J., Duffull, S. B., Hackett, L. P., & Ilett, K. F. (2002). Studying drugs in human milk: Time to unify the approach. Journal of Human Lactation, 18(4), 323-332.

Slide 20 of 22

So, what are the key points of this section? SSRI medications in general have low passage into the breastmilk and all of them are considered compatible with breastfeeding. Fluoxetine has a longer half-life which led to early anecdotal concern about increased half-life and increased case reports early on about adverse reactions but that doesn't mean there's reason to stop it for breastfeeding if it's the medication that works well for the patient. Remember that older drugs have more data. 
Free Files
Success!
Check your inbox, we sent you all the materials there.

Slide 21 of 22

Sertraline has evidence of the lowest passage into the breastmilk but again choose the drug that works for the patient. And other classes of antidepressants are also considered compatible with breastfeeding.

Slide 22 of 22

Free Files
Success!
Check your inbox, we sent you all the materials there.

Learning Objectives:

After completing this activity, the learner will be able to:

  1. Assess the risks and benefits of breastfeeding while the mother is using psychotropics.
  2. Describe the tools for calculating the amount of exposure for the infant.
  3. Decide whether breastfeeding is safe on a case-by-case basis.

Original Release Date: 08/01/2021

Review and Re-release Date: 03/01/2024

Expiration Date: 04/01/2025

Expert: Lauren Osborne, M.D.

Medical Editor: Lorena Rodriguez, M.D

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationship(s) to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

  1. View the required educational content provided on this course page.
  2. Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
  3. Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Free Files
Success!
Check your inbox, we sent you all the materials there.
Continue in the website
Instant access modal

Become a Bronze, Silver, Gold, Bronze extended, Silver extended or Gold extended Member.

2025–26 Psychopharmacology CME Program

Unlock up to 155 CME Credits, including 40 SA CME Credits.